1. Franco P. Orphan drugs: the regulatory environment. Drug Discov Today. 2013;18(3–4):163–72.
2. Rare Diseases Act of 2002. Bill Number H.R. 4013 for the 107th Congress [Internet]. [cited 2022 Jan 24]. Available from: https://www.congress.gov/107/crpt/hrpt543/CRPT-107hrpt543.pdf.
3. Orphan Drug Regulation (EC) No 141/2000 [Internet]. [cited 2022 Jan 24]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32000R0141.
4. Profitability and market value of orphan drug companies: a retrospective, propensity-matched case-control study;Hughes;PLoS ONE,2016
5. Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation;Kesselheim;Health Law, Ethics Human Rights,2010